These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37632495)

  • 1. Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy: State-of-the-Art Review and an Updated Analysis From UNOS.
    Liang LW; Lumish HS; Sewanan LR; Shimada YJ; Maurer MS; Weiner SD; Sayer G; Uriel N; Clerkin KJ
    JACC Heart Fail; 2023 Nov; 11(11):1473-1480. PubMed ID: 37632495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy.
    Maron BJ; Rowin EJ; Udelson JE; Maron MS
    JACC Heart Fail; 2018 May; 6(5):353-363. PubMed ID: 29655822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.
    Rowin EJ; Maron BJ; Kiernan MS; Casey SA; Feldman DS; Hryniewicz KM; Chan RH; Harris KM; Udelson JE; DeNofrio D; Roberts WC; Maron MS
    Circ Heart Fail; 2014 Nov; 7(6):967-75. PubMed ID: 25239116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Olivotto I; Casey SA; Arretini A; Tomberli B; Garberich RF; Link MS; Chan RHM; Lesser JR; Maron BJ
    J Am Coll Cardiol; 2016 Mar; 67(12):1399-1409. PubMed ID: 27012399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Heart Failure Management and Transplantation.
    Levine A; Gupta CA; Gass A
    Cardiol Clin; 2019 Feb; 37(1):105-111. PubMed ID: 30447710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    Rowin EJ; Maron BJ; Carrick RT; Patel PP; Koethe B; Wells S; Maron MS
    J Am Coll Cardiol; 2020 Jun; 75(24):3033-3043. PubMed ID: 32553256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.
    Smith ED; Tome J; Mcgrath R; Kumar S; Concannon M; Day SM; Saberi S; Helms AS
    Int J Cardiol; 2019 Jan; 274():226-231. PubMed ID: 30075967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
    Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
    Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated left ventricular non-compaction: an unusual indication for heart transplantation.
    Fan KY; Chan CW; Cheng LC; Ko RL; Lam YM; Jim MH; Au TW; Ho CK; Wang EP; Chau EM; Chow WH
    Hong Kong Med J; 2009 Oct; 15(5):378-80. PubMed ID: 19801696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction.
    Yagi N; Seguchi O; Mochizuki H; Kuroda K; Nakajima S; Watanabe T; Yanase M; Tadokoro N; Fukushima S; Fujita T; Fukushima N
    ESC Heart Fail; 2021 Dec; 8(6):5513-5522. PubMed ID: 34708560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study.
    Re F; Halasz G; Moroni F; Beltrami M; Baratta P; Avella A; Zachara E; Olivotto I
    Int J Cardiovasc Imaging; 2022 Nov; 38(11):2345-2352. PubMed ID: 36434342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy.
    Pasqualucci D; Fornaro A; Castelli G; Rossi A; Arretini A; Chiriatti C; Targetti M; Girolami F; Corda M; Orrù P; Matta G; Stefàno P; Cecchi F; Porcu M; Olivotto I
    Circ Heart Fail; 2015 Nov; 8(6):1014-21. PubMed ID: 26446673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.